New 3D mapping system for treating paroxysmal AF
Part of Heart & circulation clinical trials.
This study tests a new 3D heart-mapping system that helps doctors navigate during a procedure to treat paroxysmal atrial fibrillation (a type of irregular heartbeat that can come and go). The system uses pressure and star-mapping technologies to make the treatment more precise and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have paroxysmal atrial fibrillation (AF) that comes and goes and your doctor recommends a procedure called catheter ablation.
- You are between 18 and 80 years old.
- You do not have a blood clot in your heart, and your heart’s pumping strength is normal (LVEF above 40%).
- You have not had a stroke, mini-stroke, or heart attack in the past 3 months.
- You have not had a prior ablation for AF, and you do not have other serious health issues like active infections, bleeding problems, or cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new balloon cryoablation system to treat paroxysmal atrial fibrillation (a type of irregular heartbeat that comes and goes). It aims to see if this device can safely and effectively restore a normal heart rhythm.
This trial tests a new tool called FARAFLEX that uses pulsed electrical energy to treat atrial fibrillation (an irregular heart rhythm). The goal is to see if this method can safely stop AF symptoms in people whose medications haven't worked.
This study tests a new catheter to treat atrial fibrillation (AF), a heart rhythm problem, in people with symptoms. It aims to see if the treatment is safe and works well for people whose AF comes and goes.
This trial tests a new catheter system (PulseMagic™ TrueForce™) to treat paroxysmal atrial fibrillation (AFib) in people who haven't gotten enough relief from medicines. It's a study for those who have not had a prior ablation and meet specific heart health criteria.
This trial tests a new catheter that can measure tissue temperature during ablation for rapid heartbeats like supraventricular tachycardia and atrial fibrillation. It aims to see if it is safe and effective.
This trial tests a new magnetic-guided catheter to treat rapid heart rhythms like atrial fibrillation or supraventricular tachycardia. It may help people who haven't found relief from medications or prefer a procedure without prior drug therapy.
Hear when a new Paroxysmal Atrial Fibrillation (PAF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.